Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2

Status

Recruiting 8Completed 4Withdrawn 2Unknown 2Terminated 2

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Carcinoma, Hepatocellular 2Ovarian Neoplasms 1Hepatic Malignancies 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Yttrium-90 × Clear all
NCT00072410 2023-10-04

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

Ludwig Institute for Cancer Research

Phase 1 Completed
7 enrolled 7 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT04332419 2022-06-22

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Case Comprehensive Cancer Center

Phase NA Completed
11 enrolled 7 charts

Hepatic Malignancies

NCT00846131 2016-09-15

Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma

Northwestern University

Phase 1 Completed
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02724436 2016-03-31

Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡